Skip to main content
ZHEJIANG HISUN BIOMATERIALS CO.LTD. logo

ZHEJIANG HISUN BIOMATERIALS CO.LTD. — Investor Relations & Filings

Ticker · 688203 ISIN · CNE100005PR6 LEI · 836800FFEHQZ20JXVV58 Shanghai Stock Exchange Manufacturing
Filings indexed 360 across all filing types
Latest filing 2026-05-22 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 688203

About ZHEJIANG HISUN BIOMATERIALS CO.LTD.

https://en.hisunplas.com/

Zhejiang Hisun Biomaterials Co., Ltd. specializes in the research, development, and industrial-scale production of polylactic acid (PLA), a biodegradable and bio-based polymer derived from renewable resources. The company offers a diverse portfolio of PLA resins under the Revode brand, tailored for applications including food packaging, disposable tableware, textile fibers, 3D printing filaments, and agricultural films. By leveraging advanced polymerization technologies, the firm provides sustainable alternatives to petroleum-based plastics, focusing on high-performance materials that meet international compostability and safety standards. Its products serve global markets in the packaging, consumer goods, and industrial sectors, supporting the transition toward a circular economy through eco-friendly material solutions.

Recent filings

Filing Released Lang Actions
浙江海正生物材料股份有限公司简式权益变动报告书(中国石化集团资本有限公司)
Major Shareholding Notification Classification · 94% confidence The document is a ‘简式权益变动报告书’ – a simplified equity change report disclosing that a major shareholder’s stake in the listed company has changed (from 5.32% to 5.00%). It provides detailed shareholding before and after, dates, and regulatory references under Chinese securities law. This fits the definition of Major Shareholding Notification (code MRQ): a notification of changes in significant share ownership levels. It is not an announcement of a report publication, not a full Annual or Interim report, nor a proxy or governance filing.
2026-05-22 Chinese
浙江海正生物材料股份有限公司关于诉讼事项的进展公告
Legal Proceedings Report Classification · 85% confidence The document is a corporate announcement detailing the progress of an ongoing lawsuit, including case phase, parties involved, amounts claimed, appeal status, court schedules, and potential impact on the company’s financials. It does not present financial statements or investor presentation materials, nor is it a proxy, dividend, or board change notice. This falls squarely under updates on significant legal matters, matching the Legal Proceedings Report category.
2026-05-21 Chinese
浙江海正生物材料股份有限公司2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "2025年年度股东会决议公告" which translates to "2025 Annual General Meeting Resolution Announcement." It details the date and location of the shareholders meeting, attendance, voting results on various proposals including the board work report, profit distribution plan, and other corporate governance matters. It also includes legal witness statements confirming the legality and validity of the meeting and resolutions. The document is a formal announcement of the voting results and resolutions passed at the Annual General Meeting (AGM). It does not contain the full AGM presentation materials or detailed financial reports, but rather the official voting results and resolutions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and is a direct announcement of voting results, not a report publication or full report itself.
2026-05-08 Chinese
浙江海正生物材料股份有限公司关于为全资子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Haizheng Biomaterials Co., Ltd. regarding the provision of guarantees for its wholly-owned subsidiary. It details the guarantee amount, the subsidiary's financials, the board's approval, and the rationale for the guarantee. The document is a formal announcement about a financing-related guarantee, not a financial report or audit. It does not contain financial statements or earnings data but focuses on a capital/financing update related to guarantees for loans. The document length is 2177 characters, which is relatively short and typical for an announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-04-13 Chinese
浙江海正生物材料股份有限公司2025年度审计报告
Audit Report / Information Classification · 96% confidence The document is a standalone audit report (“审计报告”) by Tianjian accounting firm, containing the auditor’s opinion, basis, key audit matters, and audited financial statements for the year ended December 31, 2025. It does not include broader narrative or disclosures typical of an Annual Report, but focuses on audit findings and financial statements. This matches the definition of an Audit Report / Information. FY 2025
2026-04-13 Chinese
浙江海正生物材料股份有限公司关于开展外汇套期保值业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Zhejiang Haizheng Biomaterials Co., Ltd. regarding the commencement of foreign exchange hedging business. It details the purpose, transaction amount, funding source, transaction methods, approval procedures, risk analysis, risk control measures, and accounting treatment related to the hedging activities. The document is a formal disclosure of a specific financing or risk management activity by the company, not a financial report or earnings release. It does not contain financial statements or comprehensive financial data but rather informs about a capital/financing update related to foreign exchange hedging. The document length is 2736 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-04-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.